ArticleScientific reports2021

CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis.

Daekwon Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.